EUVIMEDEUVIMED entdecken
Vergleichsstudie

Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies

Xu Zhu, Bo Zhang, Qi Kong, Yuheng Li, Pengfei Fan, Dengbin Wu

Brachytherapy · 2025

DOI: 10.1016/j.brachy.2025.06.002 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Brachytherapy, 2025. Verfasst von Xu Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Ansteel Group Hospital, Anshan, Liaoning, China. Hauptthemen laut MEDLINE: Radiosurgery, Liver Neoplasms, Iodine Radioisotopes, Brachytherapy. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Liaoning Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aims to compare the dosimetric values of I-125 seed implantation with stereotactic body radiotherapy (SBRT) in the treatment of hepatic cancer patients. METHODS AND MATERIALS: The study retrospectively analyzed 23 patients with hepatic malignancies treated with SBRT. A virtual I-125 seed implantation plan was simulated for comparison. For I-125 seed implantation, a prescription dose of 110 Gy was delivered to the gross tumor volume (GTV), corresponding to the planned target volume (PTV) in SBRT. Dosimetric values, including target coverage and dose to organs at risk (OARs), were compared using paired t-tests. RESULTS AND CONCLUSIONS: The average PTV volume receiving 100% of the prescription dose was similar between the I-125 and SBRT groups (86.0% vs. 78.7%, p = 0.172). The I-125 group mean PTV V150% 62.9% ± 8.5%, while SBRT plans inherently restrict maximum PTV doses to ≤150% (resulting in 0% V150%). The mean minimum dose to PTV was significantly greater in the I-125 group than in the SBRT group (5562.49 cGy vs. 3289.69 cGy, p < 0.01). Regarding OARs, the liver volume receiving ≥15 Gy was significantly lower in the I-125 group (274.67 cc vs. 485.72 cc, p < 0.01), with similar trends observed for the small intestine, kidneys, stomach, and colon. Dosimetric analysis revealed differences in dose distribution within the target volume and efficient OARs sparing using I-125 seed implantation compared with SBRT. Additional studies are required to examine the clinical relevance of these findings and determine whether combining these two methods may offer higher therapeutic benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryLiver NeoplasmsIodine RadioisotopesBrachytherapyHumansMaleRetrospective StudiesFemaleRadiotherapy DosageAgedMiddle AgedRadiotherapy Planning, Computer-AssistedOrgans at RiskAged, 80 and overRadiometry

Stichwörter der Autor:innen

Hepatic malignanciesI-125 seed implantationSBRTStereotactic body radiotherapy

Substanzen

Iodine RadioisotopesIodine-125

Autor:innen und Institutionen

  • Department of Radiation Oncology, Ansteel Group Hospital, Anshan, Liaoning, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China. Electronic address: zhb100b@163.com.
  • Department of Radiation Oncology, Ansteel Group Hospital, Anshan, Liaoning, China. Electronic address: dengbinwuu@outlook.com.

Förderung

  • Liaoning Provincial Natural Science Foundation

Zitieren

APA

Zhu, X., Zhang, B., Kong, Q., Li, Y., Fan, P., & Wu, D. (2025). Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies. Brachytherapy. https://doi.org/10.1016/j.brachy.2025.06.002

Vancouver

Zhu X, Zhang B, Kong Q, Li Y, Fan P, Wu D. Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies. Brachytherapy. 2025. doi:10.1016/j.brachy.2025.06.002

BibTeX
@article{Zhu2025,
  author = {Zhu, Xu and Zhang, Bo and Kong, Qi and Li, Yuheng and Fan, Pengfei and Wu, Dengbin},
  title = {Dosimetric comparison between I-125 seed implantation and stereotactic body radiotherapy (SBRT) in patients with hepatic malignancies},
  journal = {Brachytherapy},
  year = {2025},
  doi = {10.1016/j.brachy.2025.06.002}
}
Kostenlos starten →